Karen Fallen, Touchlight CEO
Pfizer lines up access to 'doggybone DNA' in manufacturing of mRNA vaccines, gene therapies and more
As Pfizer builds a whole franchise of genetic products on the cornerstone of its mRNA Covid-19 vaccine, it’s testing out a new way to manufacture …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
